EQS Group-News: RELIEF THERAPEUTICS Holdings AG / Key word(s): Miscellaneous02.06.2021 / 07:00 Relief Therapeutics Reports that its Collaboration Partner, NRx Pharmaceuticals, has Submitted an Application for Emergency Use Authorization for Aviptadil to the U.S. Food & Drug Administration Geneva, Switzerland, Ju.
Relief Announces Notice of Annual General Meeting of RELIEF THERAPEUTICS Holding AG streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
GENEVA, SWITZERLAND / ACCESSWIRE / May 28, 2021 / RELIEF THERAPEUTICS Holding AG (SIX:RLF)(OTCQB:RLFTF) ("Relief" or the "Company"), a biopharmaceutical company with its lead compound RLF-100TM (aviptadil)
EQS Group-News: RELIEF THERAPEUTICS Holdings AG / Key word(s): Personnel28.05.2021 / 07:00 Relief Appoints Dr. Taneli Jouhikainen as Chief Operating OfficerGeneva, Switzerland, May 28, 2021 - RELIEF THERAPEUTICS Holding AG (SIX: RLF, OTCQB: RLFTF) ("Relief" or the "Company"), a biopharmaceutical company with its lea.
Relief Appoints Dr Taneli Jouhikainen as Chief Operating Officer streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.